Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $78.34M in the quarter ending March 31, 2025, with 183.68% growth. This brings the company's revenue in the last twelve months to $233.67M, up 449.03% year-over-year. In the year 2024, Tarsus Pharmaceuticals had annual revenue of $182.95M with 948.62% growth.

• Revenue (ttm): $233.67M
• Revenue Growth: +449.03%
• P/S Ratio: 6.74
• Revenue / Employee: $723,449
• Employees: 323
• Market Cap: 1.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	182.95M	165.51M	948.62%
Dec 31, 2023	17.45M	-8.37M	-32.42%
Dec 31, 2022	25.82M	-31.21M	-54.73%
Dec 31, 2021	57.03M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.